These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7333090

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A long-term observation of the platelet monoamine oxidase activity in schizophrenic patients (author's transl)].
    Shohmori T, Kaneyuki T, Doi T, Mitani K, Kohsaka M.
    Seishin Shinkeigaku Zasshi; 1978 Mar; 80(3):121-4. PubMed ID: 662975
    [No Abstract] [Full Text] [Related]

  • 5. Platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG, Becker RE.
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 1153659
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.
    Hitzemann R, Hirschowitz J, Zemlan F, Hitzemann B, Garver D.
    Biol Psychiatry; 1983 Dec; 18(12):1503-7. PubMed ID: 6661478
    [No Abstract] [Full Text] [Related]

  • 9. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia.
    Malas KL, van Kammen DP, deFraites EA, Brown GM, Gold PW.
    Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients.
    Freed WJ, Kleinman JE, Karson CN, Potkin SG, Murphy DL, Wyatt RJ.
    Biol Psychiatry; 1980 Apr; 15(2):329-32. PubMed ID: 7417620
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Delusional misidentification and platelet monoamine oxidase.
    Barton JL, Chaparala S, Barton ES, Jackson IV, Davis LG.
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [Abstract] [Full Text] [Related]

  • 17. Studies of MAO concentration and activity in schizophrenic patients.
    Abell CW, Fritz RB, Landowski J, Bessman JD, Castellani S, Boeringa JA, Rose RM.
    Prog Clin Biol Res; 1982 Apr; 79():209-21. PubMed ID: 7088965
    [No Abstract] [Full Text] [Related]

  • 18. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B, Kosower N, Zipser Y, Shreiber-Schul N, Apter A, Tyano S, Weizman A.
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [Abstract] [Full Text] [Related]

  • 19. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE, Wise CD, Potkin SG, Zalcman S, Phelps BH, Lovenberg W, Wyatt RJ.
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.